Macroaxis: Personalized Investing
Personalized Investing and
Digital Wealth Optimization

JNJ NVS PFE MRK Synthetics BRL Bitcoins Corporate Bonds 
Benchmark  United States  NYSE  10,542   35.986 Index Moved Up 0.34%  


Processing
Processing. Please wait...

Pfizer comparative analysis

 
 Companies |  Insiders  | Dashboard  
     
 
Refresh
You can use this module to analyze advantages of Pfizer technical and fundamental indicators over its peers. Please use the box above to enter up to 8 concurrent symbols you would like to analyze. Use comma (,) to separate each symbol. With this comparative module your can estimate the relative strength of Pfizer Inc against its competitors. See also Pfizer Backtesting, Pfizer Volatility, Pfizer Valuation, Pfizer Correlation, Pfizer History and Pfizer Performance

    
 Better Than Average     
    
 Worse Than Peers or Benchmark    View Performance Chart
Macroaxis: 0.86 Moved Up
0.26 / 0.86%
 30.35 
United States
 Pfizer
Macroaxis: 0.45 Moved Up
0.44 / 0.45%
 99.19 
United States
 Johnson
Macroaxis: 0.41 Moved Up
0.35 / 0.41%
 84.76 
United States
 Novartis
Macroaxis: 0.57 Moved Up
0.32 / 0.57%
 56.58 
United States
 Merck
Macroaxis: change 1.47 Moved Up
0.76 / 1.47%
 52.43 
United States
 Sanofi
Macroaxis: 0.29 Moved Down
(0.16) / 0.29%
 52.66 
United States
 GSK
Macroaxis: 0.71 Moved Up
0.35 / 0.71%
 49.46 
United States
 BristolMyers
Macroaxis: 0.02 Moved Down
(0.01) / 0.02%
 63.52 
United States
 AstraZeneca
Market Performance
(Over the last 30 days)
 0 of 100 13 of 100 4 of 100 0 of 100 5 of 100 0 of 100 0 of 100 0 of 100
Probability Of Bankruptcy
(Chance of Financial Distress)
27.4 %2.94 %8.58 %15.09 %14.07 %35.17 %11.47 %14.79 %
Beta
Operating Margin
Profit Margin
Current Ratio
Price to Book
Price to Earning
Return On Asset
Shares Owned by Insiders
Gross Profit
Price to Earnings To Growth
Return On Equity
One Year Low
Cash Flow from Operations
Shares Owned by Institutions
Shares Outstanding
Number of Shares Shorted
Working Capital
Debt to Equity
Cash per Share
Total Asset
Market Capitalization
Current Liabilities
Book Value Per Share
Short Ratio
Retained Earnings
EBITDA
Net Income
Total Debt
Price to Sales
Cash and Equivalents
Revenue
Z Score
Current Asset
Earnings Per Share
One Year High
Current Valuation
Day Median Price
Rate Of Daily Change
Accumulation Distribution
Market Facilitation Index
Day Typical Price
Price Action Indicator
Daily Balance Of Power
Expected Short fall
Treynor Ratio
Coefficient Of Variation
Variance
Market Risk Adjusted Performance
Downside Deviation
Jensen Alpha
Information Ratio
Skewness
Mean Deviation
Semi Variance
Maximum Drawdown
Potential Upside
Risk Adjusted Performance
Kurtosis
Standard Deviation
Semi Deviation
Sortino Ratio
Total Risk Alpha
Downside Variance
Value At Risk
Macroaxis: 0.86 Moved Up
0.26 / 0.86%
 30.35 
United States
 Pfizer
Macroaxis: 0.45 Moved Up
0.44 / 0.45%
 99.19 
United States
 Johnson
Macroaxis: 0.41 Moved Up
0.35 / 0.41%
 84.76 
United States
 Novartis
Macroaxis: 0.57 Moved Up
0.32 / 0.57%
 56.58 
United States
 Merck
Macroaxis: change 1.47 Moved Up
0.76 / 1.47%
 52.43 
United States
 Sanofi
Macroaxis: 0.29 Moved Down
(0.16) / 0.29%
 52.66 
United States
 GSK
Macroaxis: 0.71 Moved Up
0.35 / 0.71%
 49.46 
United States
 BristolMyers
Macroaxis: 0.02 Moved Down
(0.01) / 0.02%
 63.52 
United States
 AstraZeneca